This post is a shorter version of my SOG report which was submitted for the InvestorOne challenge.
You can vote for the Evergreen Investing report here. Note that you can vote for more than 1 report in the InvestorOne challenge and there’s a lucky draw prize (DJI drone) for voters!
Singapore O&G (SOG) is a healthcare company focusing on specialist practices such as obstetrics, dermatology, gynae-oncology, and paediatrics. SOG was incorporated in 2011 and listed on the SGX in 2015 with 7 doctors. Since its IPO, SOG has grown headcount mainly through doctor recruitment rather than acquisitions. The company’s only acquisition to date involved the acquisition of Dr Joyce Lim’s dermatology practice in end-2015.
SOG financials 2017 2018 2019 2020 2021 Revenue 29.9 34.7 38.8 40.4 41.8 Net profit 8.5 9.1 10.4 11.4 13.6 Recurring net profit 8.5 10.8 10.4 11.4 13.6 Recurring net profit growth -3% 27% -4% 10%...
